Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Best African American Response to Asthma Drugs (BARD)
NCT01967173Phase 3Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Feb 2014
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate nasal spray, salmeterol + fluticasone in asthma, sponsored by Penn State Health Milton S. Hershey Medical Center. Started Feb 2014; status: completed.
02
Drugs
fluticasone propionate nasal spraysalmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01967173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01967173.